Fox Run Management’s Core Laboratories CLB Stock Holding History

Fox Run Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$167K	Buy	+14,325	New	+$204K	0.03%	833
2025 Q4	–	Sell	-18,531	Closed	-$229K	–	948
2025 Q3	$229K	Buy	18,531 +1,038	+6%	+$12.2K	0.04%	767
2025 Q2	$202K	Buy	+17,493	New	+$207K	0.03%	749
2019 Q2	–	Sell	-4,327	Closed	-$298K	–	449
2019 Q1	$298K	Buy	+4,327	New	+$290K	0.17%	271
2018 Q1	–	Sell	-4,732	Closed	-$518K	–	736
2017 Q4	$518K	Buy	+4,732	New	+$472K	0.15%	279
2016 Q3	–	Sell	-3,400	Closed	-$421K	–	510
2016 Q2	$421K	Buy	+3,400	New	+$410K	0.2%	173

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fox Run Management's CLB Position: Q2 2026 in Review

Fox Run Management opened a new position in Core Laboratories (CLB) in Q2 2026: 14,325 shares worth $167K. The stake represents 0.03% of the portfolio and ranks #833 among its holdings. This is a return to the name: Fox Run Management previously reported a position in CLB as recently as Q3 2025.

Fox Run Management first reported a position in CLB in Q2 2016 and has held it in 6 quarters since. The position peaked at $518K in Q4 2017. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Fox Run Management held 14,325 shares of Core Laboratories worth $167K as of Q2 2026.
Core Laboratories was a new Fox Run Management position in Q2 2026.
Core Laboratories made up 0.03% of Fox Run Management's portfolio in Q2 2026, its #833 holding.
Fox Run Management first reported a position in Core Laboratories in Q2 2016 and has held it in 6 quarters since.
Fox Run Management's Core Laboratories position peaked at $518K in Q4 2017.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.